The biotechnology sector’s outperformance amid the pandemic has led some analysts to refer to this time as the “golden period of biotechnology”. When it comes to the best biotech stock picks, the author of today’s article identifies three parameters to consider: “hedge fund and institutional investor sentiment towards the stock, market performance, quarterly results and competitive advantage.” With this in mind, he highlights three biotech stocks that appear poised for massive growth going forward – and, not surprisingly, all three are participants in the race for a COVID-19 vaccine. For more, CLICK HERE.
When it comes to the biotechnology sector, the author of today’s article notes that it’s “an investment sector where you can become rich and it can be where you lose everything.” The key to maximizing your chances of achieving the former outcome (and minimizing your chances of falling victim to the latter outcome), he asserts, is knowing how to evaluate biotechnology investments – and he proceeds to outline how to do just that. For more, CLICK HERE.